China Biopharmaceutical Co., Ltd. has annual revenue of RMB 26.20 billion and net profit of RMB 2.33 billion for the year of 2023.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.